4.7 Review

Nanoscale delivery systems for microRNAs in cancer therapy

Journal

CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 77, Issue 6, Pages 1059-1086

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s00018-019-03317-9

Keywords

miRNA therapy; Nanodelivery; Nanoparticles; Cancer

Funding

  1. Competitivity Operational Program, 2014-2020, entitled Clinical and economical impact of personalized targeted anti-microRNA therapies in reconverting lung cancer chemoresistance-CANTEMIR [35/01.09.2016, MySMIS 103375]
  2. Project entitled Advanced innovative approaches for predictive regenerative medicine- REGMED [PN-III-P1-1.2-PCCDI-2017-0782, 65PCCDI/2018]
  3. project PNCDI III 2015-2020 entitled Increasing the performance of scientific research and technology transfer in translational medicine through the formation of a new generation of young researchers - ECHITAS [29PFE/18.10.2018]
  4. project entitled Sustenance and valorification of research of excellence in the domain of personalized medicine by internationalization and increasement of research activities visibility [CNFIS-FDI-2019-0666]

Ask authors/readers for more resources

Concomitant with advances in research regarding the role of miRNAs in sustaining carcinogenesis, major concerns about their delivery options for anticancer therapies have been raised. The answer to this problem may come from the world of nanoparticles such as liposomes, exosomes, polymers, dendrimers, mesoporous silica nanoparticles, quantum dots and metal-based nanoparticles which have been proved as versatile and valuable vehicles for many biomolecules including miRNAs. In another train of thoughts, the general scheme of miRNA modulation consists in inhibition of oncomiRNA expression and restoration of tumor suppressor ones. The codelivery of two miRNAs or miRNAs in combination with chemotherapeutics or small molecules was also proposed. The present review presents the latest advancements in miRNA delivery based on nanoparticle-related strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available